Trial intelligence / Profile preview

MR imaging to diagnose endometriosis using Ablavar – feasibility study

2012-002991-15Phase 4Active

Start
Oct 2012
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of gadofosveset in endometriosis. Primary endpoint: Laparoscopy. Started Oct 2012; status: active.

02

Drugs

gadofosveset
03

Conditions

endometriosis

Beyond the preview

Go deeper on 2012-002991-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-002991-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call